JPWO2022186335A1 - - Google Patents

Info

Publication number
JPWO2022186335A1
JPWO2022186335A1 JP2023503945A JP2023503945A JPWO2022186335A1 JP WO2022186335 A1 JPWO2022186335 A1 JP WO2022186335A1 JP 2023503945 A JP2023503945 A JP 2023503945A JP 2023503945 A JP2023503945 A JP 2023503945A JP WO2022186335 A1 JPWO2022186335 A1 JP WO2022186335A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503945A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022186335A1 publication Critical patent/JPWO2022186335A1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023503945A 2021-03-03 2022-03-03 Pending JPWO2022186335A1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021033555 2021-03-03
PCT/JP2022/009132 WO2022186335A1 (ja) 2021-03-03 2022-03-03 副作用の予測方法およびそのための装置

Publications (1)

Publication Number Publication Date
JPWO2022186335A1 true JPWO2022186335A1 (ko) 2022-09-09

Family

ID=83155095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503945A Pending JPWO2022186335A1 (ko) 2021-03-03 2022-03-03

Country Status (2)

Country Link
JP (1) JPWO2022186335A1 (ko)
WO (1) WO2022186335A1 (ko)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4360709A3 (en) * 2011-01-13 2024-07-03 Regeneron Pharmaceuticals, Inc. Use of a vegf antagonist to treat angiogenic eye disorders
US11912784B2 (en) * 2019-10-10 2024-02-27 Kodiak Sciences Inc. Methods of treating an eye disorder

Also Published As

Publication number Publication date
WO2022186335A1 (ja) 2022-09-09

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ko)
BR112023012656A2 (ko)
BR112021014123A2 (ko)
BR112022024743A2 (ko)
BR102021018859A2 (ko)
BR102021015500A2 (ko)
BR112022009896A2 (ko)
BR102021007058A2 (ko)
BR102020022030A2 (ko)
BR112023011738A2 (ko)
JPWO2022186335A1 (ko)
BR112023016292A2 (ko)
BR112023004146A2 (ko)
BR112023011539A2 (ko)
BR112023011610A2 (ko)
BR112023008976A2 (ko)
BR112023009656A2 (ko)
BR112023006729A2 (ko)
BR102021020147A2 (ko)
BR102021018926A2 (ko)
BR102021018167A2 (ko)
BR102021017576A2 (ko)
BR102021016837A2 (ko)
BR102021016551A2 (ko)
BR102021016375A2 (ko)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231124

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20231124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231213